SLC22A4 and cancer: A screening of the mRNA expression level of solute carriers in the NCI-60 cancer cell line panel (60 cancer cell lines) showed that OCTN1 was highly expressed in renal carcinoma cell lines and weakly expressed in colorectal and melanoma cancer cell lines [119].